# Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

> **NCT00561795** · PHASE2 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 12 (actual)

## Conditions studied

- Primary Peritoneal Carcinoma
- Tumor
- Epithelial Ovarian Cancer
- Uterine Disease
- Cervix Diseases
- Neoplasms, Ovarian
- Cancer

## Interventions

- **DRUG:** pazopanib (GW786034)
- **DRUG:** carboplatin
- **DRUG:** paclitaxel

## Key facts

- **NCT ID:** NCT00561795
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00561795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00561795, "Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00561795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*